HBW Advisory Services LLC trimmed its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 44.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,013 shares of the semiconductor company’s stock after selling 1,598 shares during the period. HBW Advisory Services LLC’s holdings in Synopsys were worth $993,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares during the last quarter. CreativeOne Wealth LLC increased its holdings in Synopsys by 26.4% in the 1st quarter. CreativeOne Wealth LLC now owns 3,388 shares of the semiconductor company’s stock worth $1,453,000 after buying an additional 707 shares during the period. Landscape Capital Management L.L.C. purchased a new position in Synopsys during the 1st quarter worth approximately $1,450,000. WPG Advisers LLC acquired a new stake in Synopsys during the 1st quarter valued at approximately $34,000. Finally, Canada Pension Plan Investment Board lifted its stake in Synopsys by 18.1% during the 1st quarter. Canada Pension Plan Investment Board now owns 53,039 shares of the semiconductor company’s stock valued at $22,746,000 after acquiring an additional 8,130 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
- Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
- Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
- Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice
Analyst Upgrades and Downgrades
View Our Latest Stock Report on SNPS
Synopsys Price Performance
NASDAQ:SNPS opened at $477.14 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The stock’s 50-day moving average price is $437.58 and its 200-day moving average price is $503.60. The stock has a market capitalization of $91.29 billion, a PE ratio of 59.72, a price-to-earnings-growth ratio of 3.97 and a beta of 1.16.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s quarterly revenue was up 37.8% on a year-over-year basis. During the same period in the prior year, the company posted $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, equities analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insider Buying and Selling
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.62% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Wall Street Stockpicker Names #1 Stock of 2026
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
- GOLD ALERT
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
